DCF — FAIRFIELD MEDICAL CENTER
Enterprise Value: $-210.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-210.8M
Enterprise Value
$-72.7M
PV of Cash Flows
$-138.1M
PV of Terminal Value
$-222.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $310.3M | $-9.9M | -3.0% | $-23.0M | $-20.9M |
| Year 2 | $319.6M | $-7.0M | -2.0% | $-20.5M | $-16.9M |
| Year 3 | $329.2M | $-3.9M | -1.0% | $-17.8M | $-13.4M |
| Year 4 | $339.1M | $-2.3M | -1.0% | $-16.6M | $-11.4M |
| Year 5 | $349.3M | $-1.5M | -0.0% | $-16.3M | $-10.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-210.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$301.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.036756969543482496
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5